Stocks · Healthcare · Medical - Devices
Neogen Corporation NEOG
$13.01 +7.08% Close, Oct 5, 2026 · NASDAQ · Market cap $2.65B
Strong trend
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +124.3%, ahead of the S&P 500 by 108.5 percentage points.
- Net debt is 3.5× EBITDA, a high level of leverage.
- The stock is in an uptrend: above its 200-day average for 206 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 26%
- Revenue growth, 3-year CAGRBottom 28%
- Revenue growth accelerationTop 35%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 33%
- Gross marginBottom 31%
- Operating marginTop 45%
- Accruals (lower is better)Bottom 28%
- Net debt / EBITDA (lower is better)Bottom 25%
- Interest coverTop 45%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 30%
- Free-cash-flow yieldTop 32%
- EBITDA / enterprise valueTop 21%
- Sales / enterprise valueTop 46%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 17%
- 6-month returnTop 29%
- 1-year return vs S&P 500Top 11%
- Distance from 52-week highTop 15%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 8%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyBottom 13%
- Upside to consensus price targetBottom 15%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 48%
- Maximum drawdown, 3 yearsBottom 36%
- Beta vs S&P 500 (lower is better)Top 43%
- Net debt / EBITDA (lower is better)Bottom 25%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -3.9% | -2.7% | ↑ |
| Gross margin | 39.8% | 46.9% | ↑ |
| Operating margin | 2.7% | -2.5% | ↓ |
| FCF margin | -5.2% | 3.7% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -2.7% | -3.9% | ↑ | Bottom 26% |
| Gross margin | 46.9% | 39.8% | ↑ | Bottom 31% |
| Operating margin | -2.5% | 2.7% | ↓ | Top 45% |
| Net margin | -0.9% | -122.1% | ↑ | — |
| Free-cash-flow margin | 3.7% | -5.2% | ↑ | — |
| Return on invested capital | -0.6% | — | Top 33% | |
| Revenue growth, 3-year CAGR | 1.9% | — | Bottom 28% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 3.53×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -0.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.06%
- Shareholder yield
- -0.06%
- Share count change, 1 year
- +0.3%
- Share count change, 3-year CAGR
- +0.2%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through May 31, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +95.2%
- Average 2-day reaction, last 8
- +3.8%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $13.50
- Target vs current price
- +3.8%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 45%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 30, 2026 | +58.8% | +22.7% | +21.3% | +24.5% | — |
| Apr 9, 2026 | +125.0% | -2.9% | -8.9% | -11.2% | -8.0% |
| Jan 8, 2026 | +42.9% | +31.6% | +27.2% | +43.5% | +29.5% |
| Oct 9, 2025 | +154.1% | +16.5% | +2.2% | +6.7% | +24.7% |
| Jul 28, 2025 | -3625.0% | +3.8% | -10.7% | +8.0% | +12.8% |
| Apr 9, 2025 | -138.5% | -28.7% | -29.7% | -15.8% | -29.3% |
| Jan 10, 2025 | -2433.3% | -5.4% | -11.2% | -20.7% | -39.9% |
| Oct 10, 2024 | -22.2% | -7.1% | -1.6% | +5.2% | -14.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 30, 2026 | $0.09 | $0.06 | +58.8% | $225.3M |
| Apr 9, 2026 | $0.09 | $0.04 | +125.0% | $211.2M |
| Jan 8, 2026 | $0.10 | $0.07 | +42.9% | $224.7M |
| Oct 9, 2025 | $0.04 | -$0.07 | +154.1% | $209.2M |
| Jul 28, 2025 | -$2.82 | $0.08 | -3625.0% | $225.5M |
| Apr 9, 2025 | -$0.05 | $0.13 | -138.5% | $221.0M |
| Jan 10, 2025 | -$2.10 | $0.09 | -2433.3% | $231.3M |
| Oct 10, 2024 | $0.07 | $0.09 | -22.2% | $217.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 42.0× | — | — | — |
| EV / EBITDA | 18.9× | — | — | Top 21% |
| EV / Sales | 3.74× | — | — | Top 46% |
| Free-cash-flow yield | 1.20% | — | — | Top 32% |
| Earnings yield | -0.26% | — | — | Top 30% |
P/E over the past five years
Range 41.0× – 471.4× since May 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 48
- Days above the 200-day average
- 206
- 50-day average slope (20 days)
- +11.7%
- 200-day average slope (20 days)
- +7.0%
- Distance from 50-day average
- +8.7%
- Distance from 200-day average
- +29.8%
- RSI (14)
- 56.0
- Relative volume
- 1.14×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 56.6%
- Volatility vs own 5-year history
- 81th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.98
- Correlation with S&P 500
- 0.24
- Current drawdown from 1-year high
- -6.9%
- Maximum drawdown, 3 years
- -78.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 20, 2021 | Apr 17, 2025 | -90.9% | 1004 days | Not yet recovered |
| Oct 1, 2020 | Oct 6, 2020 | -13.3% | 3 days | 45 days (Dec 9, 2020) |
| Feb 12, 2021 | Mar 4, 2021 | -12.2% | 13 days | 19 days (Mar 31, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.65B
- EPS, diluted (TTM)
- -$0.03
- Revenue (TTM)
- $870.4M
- 52-week range
- $5.37 – $14.26
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $527.2M | $822.4M | $924.2M | $894.7M | $870.4M |
| Gross profit | $243.0M | $406.0M | $462.6M | $421.4M | $408.5M |
| Operating income | $58.6M | $37.5M | $77.4M | $9.4M | -$21.6M |
| Net income | $48.3M | -$22.9M | -$9.4M | -$1.09B | -$7.9M |
| EPS (diluted) | $0.45 | -$0.12 | -$0.04 | -$5.03 | -$0.04 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $217.0M | $231.3M | $221.0M | $225.5M | $209.2M | $224.7M | $211.2M | $225.3M |
| Net income | -$12.6M | -$456.3M | -$11.0M | -$612.2M | $36.3M | -$15.9M | -$17.0M | -$11.3M |
| EPS (diluted) | -$0.06 | -$2.10 | -$0.05 | -$2.82 | $0.17 | -$0.07 | -$0.08 | -$0.05 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $68.0M | $41.0M | $35.3M | $58.2M | $83.2M |
| Capital expenditure | -$24.4M | -$65.8M | -$111.4M | -$104.6M | -$51.3M |
| Free cash flow | $43.6M | -$24.7M | -$76.2M | -$46.4M | $31.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $7.9M | $1.2M | $2.5M | $2.2M | $1.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $185.5M
- Total assets
- $3.35B
- Total liabilities
- $1.25B
- Total debt
- $793.3M
- Net debt
- $607.8M
- Shareholders’ equity
- $2.09B
As of May 31, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 11,168,684
- Days to cover
- 4.53
- Change vs previous report
- +5.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 7, 2021
- 2-for-1
- Jan 2, 2018
- 1,333-for-1,000
- Oct 31, 2013
- 3-for-2
- Dec 16, 2009
- 3-for-2
- Sep 5, 2007
- 3-for-2